Improving hepatocellular carcinoma screening among cirrhosis patients
Improving hepatocellular carcinoma screening among cirrhosis patients from North Carolina using lab-based risk stratification tools aims to improve hepatocellular carcinoma (HCC) screening and outcomes in North Carolina, particularly among patients in resource-limited settings.
